Health-related quality of life in patients with chemical warfare-induced chronic obstructive pulmonary disease

Archives of Iranian Medicine

Volumn 9, Issue 4, 2006, Pages 359-363

  Attaran, Davood ^a   Khajedaloui, Mohammad ^a   Jafarzadeh, Reza ^a   Mazloomi, Maryam ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical warfare; Chronic obstructive pulmonary disease; Quality of life; St George Respiratory Questionnaire

Indexed keywords

CHEMICAL WARFARE AGENT;

ADULT; ARTICLE; CALCULATION; CHEMICAL WARFARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; MALE; PRACTICE GUIDELINE; PREDICTION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; ST GEORGE RESPIRATORY QUESTIONNAIRE;

ADULT; CHEMICAL WARFARE; HUMANS; MALE; MIDDLE AGED; MUSTARD GAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 33751319004     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Emad A, Rezaian GR. The diversity of sulfur mustard gas inhalation on respiratory system 10 years after a single heavy exposure: analysis of 197 cases. Chest. 1997; 112: 734-738.
2. Balali M. Clinical and laboratory findings in Iranian fighters with chemical gas poisoning proceeding of the First World Congress on Biological and Chemical Warfare. Ghent Universal Press. 1984; (suppl): 254-259.
3. Okbadejo AA, Jones PW, Wedzich JA. Quality of life in patients with COPD and severe hypoxemia. Thorax. 1996; 51: 44-47.
4. Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002; 166: 680-685.
5. Jones PW, Quirk FH, Baveystock CM. The St George Respiratory Questionnaire. Respir Med. 1991; 85: 25-31.
6. Jones PW, Quirk FH, Baveystock CM, LittleoJohns P. A self complete measures of health status for chronic airflow limitation. The St George Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145: 1321-1327.
7. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD. Functional status and well being of patients with chronic conditions: results from the medical outcomes study. JAMA. 1989; 262: 907-913.
8. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med. 1997; 155: 1283-1289.
9. Okubadejo AA, Paul EA, Jones PW, Wedzich JA. Does long-term oxygen therapy affect quality of life in patients with COPD and severe hypoxemia? Eur Respir J. 1996; 9: 2335-2339.
10. Eiser N, West C, Evans S, Quirk F. Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J. 1997; 10: 1581-1584.
11. Ketelaars CA, Abu-Saad HH, Scholossr MA, Mostert M, Wouters EF. Long-term outcome of pulmonary rehabilitation in patients with COPD. Chest. 1997; 112: 363-369.
12. Aaron SD, Vandemheen KL, Clinch JJ, Ahuja J, Brison RJ, Dickinson G, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002; 121: 688-696.
13. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med. 1997; 127: 1072-1079.
14. No authors listed. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152: S77-S121.
15. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD: NHLBI/ WHO Workshop report. US Department of Health and Human Services. Bethesda: NIH Publication; 2001.
16. Prigatano GP, Wright FC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and COPD. Arch Intern Med. 1984; 144: 1613-1619.
17. McSweeny AJ, Heaton RK, Adams KM. Life quality of patients with COPD. Arch Intern Med. 1982; 142: 473-478.
18. Alonso J, Anto JM, Gonzalez M, Fiz JA, Izquierdo J, Morera J. Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients. Med Care. 1992; 30 (5 suppl): S125-S135.
19. Engstrom CP, Person CO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease specific and generic measures should be used. Eur Respir J. 2001; 18: 67-76.
20. Ketelaars CA, Schlosser MA, Mostert R, Huyer Abu-Saad H, Halfens RJ, Wouters EF. Determination of health-related quality of life in patients with COPD. Thorax. 1996; 51: 39-43.
21. Cesar LA, Ramires JA, Serrano Junior CV, Meneghetti JC, Antonelli RH, da-Luz PL, et al. Comorbidity contributes to predict mortality of patients with COPD. Eur Respir J. 1997; 10: 2794-2800.
22. Cesar LA, Ramires JA, Serrano Junior CV, Meneghetti JC, Antonelli RH, da-Luz PL, et al. Interpretation of quality of life scores from the St George Respiratory Questionnaire. Eur Respir J. 2002; 19: 405-413.